13F Holdings
中文EN

LODE Comstock Inc.

Industrial Organic Chemicals · NYSE · SEC CIK 1120970 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-52.2%
TTM net income YoY7.1%
TTM EPS YoY—
Revenue 3-yr CAGR15.7%
Net income 3-yr CAGR—

Margins

Gross margin-151.8%
Operating margin-3,535.2%
Net margin-3,680.5%
FCF margin—
EBITDA margin-3,173.9%

Returns

ROE-38.2%
ROA-27.2%
ROIC (approx.)-40.2%
Asset turnover0.01x

Leverage & solvency

Liabilities / assets22.9%
Debt / equity0.00x
Current ratio3.31x
Interest coverage-67.29x

Cash quality & payout

Operating cash flow / net income0.64x
Accruals ratio-9.8%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.55M$3.02M$1.27M$178,150$862,165
Cost of revenue$2.63M$451,938$0$0$272,082
Gross profit-$1.07M$2.56M$1.27M$178,150$590,083
R&D expense$12.32M$19.10M$6.12M$7.02M$414,751
SG&A expense$20.67M$12.70M$12.59M$10.24M$5.55M
Operating income-$38.15M-$39.67M-$12.60M-$19.36M-$6.41M
Interest expense$1.93M$2.97M$1.65M$1.65M$168,881
Pretax income$43.08M$53.32M—-$46.74M-$30.33M
Income tax$0$0$0$0-$5.75M
Net income-$43.08M-$53.32M$9.16M-$46.74M-$24.58M
EBITDA-$34.31M-$37.42M-$10.13M-$16.03M-$5.37M
EPS (basic)-1.17-3.210.87-0.62-0.49
EPS (diluted)-1.17-3.210.87-0.62-0.49
Weighted avg. shares (diluted)36.71M16.61M10.52M74.46M50.42M
Banking
Deposits——$410,100$422,603—
Balance sheet
Cash & equivalents$16.95M$954,271$3.79M$2.52M$5.91M
Short-term investments—$0$18.91M$0—
Receivables$1.29M$2.42M$26,364$4.99M—
Current assets$20.66M$12.56M$23.18M$30.77M$13.83M
PP&E, net$29.89M$8.61M$15.20M$13.47M$14.56M
Goodwill$1.51M$0—$0$12.79M
Intangibles$26.45M$5.86M$15.87M$17.66M$23.18M
Total assets$169.60M$91.31M$106.47M$100.05M$126.95M
Current liabilities$10.02M$8.11M$14.84M$31.63M$23.91M
Short-term debt$0$97,593$4.50M$1.80M$0
Long-term debt$0$8.39M$5.36M$6.12M$4.49M
Total debt$0$8.49M$9.85M$7.92M$4.49M
Total liabilities$58.70M$31.54M$28.19M$43.69M$33.98M
Shareholders' equity$107.58M$59.77M$78.28M$53.60M$89.57M
Net debt-$16.95M$7.53M$6.07M$5.40M-$1.43M
Shares outstanding51.85M23.51M11.79M91.44M71.21M
Cash flow statement
Operating cash flow-$24.39M-$13.94M-$13.63M-$12.11M-$7.49M
Capital expenditure——$1.82M$1.01M$78,467
Free cash flow——-$15.44M-$13.12M-$7.57M
Investing cash flow-$21.98M-$6.48M$3.63M-$3.73M-$16.10M
Financing cash flow$62.36M$17.59M$11.26M$12.45M$27.07M
Depreciation & amortization$3.84M$2.24M$2.48M$3.33M$1.03M
Stock-based compensation$0$41,799-$2,256$481,997$463,986

Free plan shows the latest 5 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.